Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
1.240
-0.020 (-1.59%)
At close: Mar 28, 2025, 4:00 PM
1.300
+0.060 (4.84%)
After-hours: Mar 28, 2025, 7:30 PM EDT
Fractyl Health Employees
Fractyl Health had 107 employees as of December 31, 2024. The number of employees increased by 5 or 4.90% compared to the previous year.
Employees
107
Change (1Y)
5
Growth (1Y)
4.90%
Revenue / Employee
$869
Profits / Employee
-$658,234
Market Cap
60.66M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 107 | 5 | 4.90% |
| Dec 31, 2023 | 102 | 19 | 22.89% |
| Dec 31, 2021 | 83 | - | - |
GUTS News
- 25 days ago - Fractyl Health, Inc. (GUTS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 25 days ago - Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates - GlobeNewsWire
- 4 weeks ago - Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025 - GlobeNewsWire
- 2 months ago - Fractyl Health Announces Increased Focus on Groundbreaking Revita® Weight Maintenance and Rejuva® Pancreatic Gene Therapy Programs with Potential to Deliver Key Clinical Milestones Across Multiple Studies in 2025 - GlobeNewsWire
- 3 months ago - Fractyl Health Unveils Promising Preclinical Data Demonstrating Safety and Feasibility of Local Delivery of RJVA-001 Rejuva® Smart GLP-1™ Pancreatic Gene Therapy at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC) - GlobeNewsWire
- 3 months ago - Fractyl Health to Present New Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC) - GlobeNewsWire
- 4 months ago - Fractyl Health to Participate in the Upcoming December Conferences - GlobeNewsWire
- 4 months ago - Fractyl Health, Inc. (GUTS) Q3 2024 Earnings Call Transcript - Seeking Alpha